rs199422161
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018136.5(ASPM):c.3796G>T(p.Glu1266*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000105 in 1,611,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018136.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- microcephaly 5, primary, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive primary microcephalyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151948Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000799 AC: 2AN: 250222 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1459740Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 726274 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151948Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74214 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:4
DNA sequence analysis of the ASPM gene demonstrated a sequence change, c.3796G>T, which results in the creation of a premature stop codon at amino acid position 1266, p.Glu1266*. This pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated ASPM protein with potentially abnormal function. This sequence change has been described in the gnomAD database in two individuals which corresponds to a population frequency of 0.0008% (dbSNP rs199422161). This pathogenic sequence change has previously been described the homozygous and compound heterozygous state in individuals with microcephaly (PMID: 30842647, 20679666, 19028728). -
ASPM: PVS1, PM2, PM3:Supporting -
Reported in the homozygous state or with a second ASPM variant, either in trans or phase unknown, in individuals with autosomal recessive primary microcephaly in the literature and referred for genetic testing at GeneDx and not observed in homozygous state in controls (PMID: 30842647, 19028728, 20679666, 22823409); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20301772, 25525159, 20679666, 34426522, 35089071, 19028728, 37599996, 30842647, 22823409) -
This variant is present in population databases (rs199422161, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with primary microcephaly (PMID: 19028728, 30842647). ClinVar contains an entry for this variant (Variation ID: 21582). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Glu1266*) in the ASPM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASPM are known to be pathogenic (PMID: 19028728, 23611254). -
Microcephaly 5, primary, autosomal recessive Pathogenic:1Other:1
- -
- -
Microcephaly Pathogenic:1
- -
Autosomal recessive primary microcephaly Pathogenic:1
Variant summary: ASPM c.3796G>T (p.Glu1266X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.9178C>T (p.Gln3060X)). The variant allele was found at a frequency of 8e-06 in 250222 control chromosomes (gnomAD). c.3796G>T has been reported in the literature in individuals affected with Primary autosomal recessive microcephaly (Nicholas_2009, Halsall_2010, Ariani_2013). In one of these reports, this variant was also found in heterozygosity, in an individual who was affected with microcephaly, but without serious cognitive dysfunction (Ariani_2013). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One submitter has provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at